Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Dec 11;95:153874. doi: 10.1016/j.phymed.2021.153874

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Elsevier GmbH. All rights reserved.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Fig. 2 — The inhibition effects of JZ on SARS-CoV-2 in vitro. (A) The cytotoxicity effects of JZ and remdesivir in Vero E6 cells was detected using a MTT assay. (B) The inhibitory effects of JZ and remdesivir on SARS-CoV-2 in vitro. (C) Inhibitory effect of JZ and remdesivir on plaque formation of SARS-CoV-2. (D) The quantitative analysis of the plaque formation in different groups was analyzed by SPSS ver. 25.0. Data were presented as the mean ± SD obtained from three separate experiments. * p < 0.05; ** p < 0.01; *** p < 0.001, compared with SARS-CoV-2-infected cells.